Please use this identifier to cite or link to this item:
http://dspace.hmtu.edu.vn/handle/DHKTYTHD_123/371| Title: | Is anti-D immunoglobulin still a frontline treatment option for immune thrombocytopenia? |
| Authors: | Despotovic, Jenny M. Neunert, Cindy E. |
| Issue Date: | 2013 |
| Publisher: | American Society of Hematology |
| Abstract: | A 5-year-old boy presents with platelet count of 2 109/L and clinical and laboratory evidence of immune thrombocytopenia. He has epistaxis and oral mucosal bleeding. Complete blood count reveals isolated thrombocytopenia without any decline in hemoglobin and he is Rh . You are asked if anti-D immunoglobulin is an appropriate initial therapy for this child given the 2010 Food and Drug Administration “black-box” warning. |
| URI: | http://220.231.117.85:8000/handle/DHKTYTHD_123/371 |
| Appears in Collections | Huyết học = Hematology |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Hematology-2013-Despotovic-283-5.pdf Restricted Access | 79.89 kB | Adobe PDF |  Request Item |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.